Results 31 to 40 of about 122,949 (273)

Joined at the hip: The role of light chain complementarity determining region 2 in antibody self-association

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2022
The amplification of weak transient protein–protein interactions to elicit robust immune responses is a recurring theme in immune processes (1) (Fig. 1).
Paul R. Sargunas, Jamie B. Spangler
semanticscholar   +1 more source

Generating Recombinant Antibodies against Putative Biomarkers of Retinal Injury. [PDF]

open access: yesPLoS ONE, 2015
Candidate biomarkers, indicative of disease or injury, are beginning to overwhelm the process of validation through immunological means. Recombinant antibodies developed through phage-display offer an alternative means of generating monoclonal antibodies
Michael R Kierny   +4 more
doaj   +1 more source

Of bits and bugs [PDF]

open access: yes, 2010
Pur-α is a nucleic acid-binding protein involved in cell cycle control, transcription, and neuronal function. Initially no prediction of the three-dimensional structure of Pur-α was possible.
Graebsch, Almut   +4 more
core   +1 more source

Half-Life Extension Enhances Drug Efficacy in Adeno-Associated Virus Delivered Gene Therapy

open access: yesEngineering, 2023
Prolonged half-life of protein-based therapeutics can improve drug efficacy. However, the impact of drug half-life on gene therapy, which inherently provides long-lasting production of the desired therapeutic protein, remains unclear.
Huifang Wu   +13 more
doaj   +1 more source

Tumor necrosis factor inhibitors in psoriatic arthritis. [PDF]

open access: yes, 2017
INTRODUCTION: Psoriatic arthritis (PsA) is a chronic inflammatory disease that can result in significant disability. With the emergence of tumor necrosis factor inhibitors (TNFi), therapeutic outcomes in PsA have improved substantially.
Kraft, Walter K.   +2 more
core   +2 more sources

Next generation Fc scaffold for multispecific antibodies

open access: yesiScience, 2021
Summary: Bispecific antibodies (Bispecifics) demonstrate exceptional clinical potential to address some of the most complex diseases. However, Bispecific production in a single cell often requires the correct pairing of multiple polypeptide chains for ...
Bram Estes   +11 more
doaj   +1 more source

Immunoglobulin G fragment crystallizable glycosylation after hematopoietic stem cell transplantation is dissimilar to donor profiles [PDF]

open access: yes, 2018
Immunoglobulin G (IgG) fragment crystallizable (Fc) N-glycosylation has a large influence on the affinity of the antibody for binding to Fcγ-receptors (FcγRs) and C1q protein, thereby influencing immune effector functions.
de Haan, N. (Noortje)   +4 more
core   +3 more sources

Efgartigimod, an FcRn antagonist, as a potential treatment for post COVID-19 syndrome

open access: yesActa Materia Medica, 2023
A significant proportion of patients who survive coronavirus disease of 2019 (COVID-19) develop a constellation of life-altering symptoms that persist long after the initial infection has resolved.
Sandra E. Reznik   +2 more
doaj   +1 more source

A Comparison of Immunoglobulin Variable Region N-Linked Glycosylation in Healthy Donors, Autoimmune Disease and Lymphoma

open access: yesFrontiers in Immunology, 2020
N-linked glycans play an important role in immunity. Although the role of N-linked glycans in the Fragment crystallizable (Fc) region of immunoglobulins has been thoroughly described, the function of N-linked glycans present in Ig-variable domains is ...
E. Vletter   +4 more
semanticscholar   +1 more source

High-level fed-batch fermentative expression of an engineered Staphylococcal protein A based ligand in E. coli: purification and characterization [PDF]

open access: yes, 2015
The major platform for high level recombinant protein production is based on genetically modified microorganisms like Escherichia coli (E. coli) due to its short dividing time, ability to use inexpensive substrates and additionally, its genetics is ...
Fernández Lahore, Marcelo   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy